Cost Effectiveness of Amphotericin B plus G-CSF Compared with Amphotericin B Monotherapy
- 1 January 1999
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 16 (5) , 543-550
- https://doi.org/10.2165/00019053-199916050-00010
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The annual cost of blood transfusions in the United KingdomClinical and Laboratory Haematology, 1998
- Liposomal Amphotericin BDrugs, 1998
- Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial ChemotherapyJournal of Antimicrobial Chemotherapy, 1997
- Antibiotic Treatment of Febrile Episodes in Neutropenic Cancer PatientsDrugs, 1997
- Economic analysis of the use of recombinant human granulocyte colony stimulating factor in autologous bone marrow transplantationEuropean Journal Of Cancer, 1996
- G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluationJournal of Clinical Pharmacy & Therapeutics, 1996
- FilgrastimDrugs, 1994
- Systemic fungal infections: major problems in cancer patients.1994
- Empiric antifungal therapy in febrile granulocytopenic patientsThe American Journal of Medicine, 1989
- Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopeniaThe American Journal of Medicine, 1982